Cadmium (Cd) exposure is an emerging environmental risk factor for atherosclerotic cardiovascular diseases (ASCVDs), particularly ischemic stroke (IS). MicroRNAs are potential mediators linking environmental exposure to health hazards. However, the role of miRNAs in the development of IS triggered by Cd exposure remains largely unknown. In this study, we first demonstrate that Cd exposure, even at a relatively low dosage (4 mg/L), significantly facilitates the progression of atherosclerosis in apolipoprotein E-deficient mice fed a high-fat diet. This pro-atherogenic effect was accompanied by comprehensive disturbances in systemic and vascular cholesterol homeostasis, evidenced by altered plasma lipid profiles, hepatic lipid accumulation, and dysregulated expression of key genes governing cholesterol uptake (CD36), efflux (ABCA1), and hydrolysis (NCEH1) within the aortic wall. Integrated transcriptomic and metabolomic analyses further corroborated the profound disruption of the lipid metabolism pathways. Through miRNA microarray, bioinformatics analysis, and qRT-PCR validation, we identified miR-30d-5p and miR-504-3p as novel epigenetic regulators mediating Cd-induced foam cell formation. Specifically, Cd treatment upregulated miR-30d-5p and downregulated miR-504-3p, which directly targeted NCEH1 and CD36, respectively, thereby promoting intracellular lipid accumulation. In a case-control population (494 IS patients and 494 controls), plasma miR-30d-5p levels were positively associated with Cd exposure and partially mediated the Cd-stroke association, accounting for 16.4% of the total effect. Moreover, miR-30d-5p significantly improved the discrimination and reclassification of IS patients beyond the traditional risk factors. In summary, our findings reveal that Cd induces atherosclerosis by disrupting cholesterol homeostasis and modulating miRNA-regulated pathways with plasma miR-30d-5p serving as a potential biomarker and mediator for Cd-related ischemic stroke. Further perspective investigations are warranted to validate our findings.
27 November 2025 in Ecotoxicology and Environmental Safety
Previous studies have evaluated the obesogenic effects of phthalates or metal(loid)s individually, but the association between their co-exposure and abdominal obesity (AOB) indices, remains largely unknown. We thus aimed to investigate the individual and combined effects of metal(loid)s and phthalates exposure on AOB among adults in Shenzhen, China. The urinary levels of 21 metal(loid)s and 11 phthalates were detected in 652 adults in this study. Significant positive associations were found between urinary phthalates, metal(loid)s levels as single contaminants and all five AOB indices, including waist circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WtHR), conicity-index (C-index) and lipid accumulation product (LAP). Bayesian Kernel Machine Regression (BKMR) models indicated that the pollutant mixture was positively associated with WHR, WtHR, C-index and LAP but not WC, and mono (2-ethyl-5-oxohexyl) phthalate (MEOHP), mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), Vanadium (V), Chromium (Cr) and Zinc (Zn) were the key contributors. Furthermore, the relationships between Cr, MEHHP and the indices C-index, WHR or LAP might be partially mediated by high sensitivity C-reactive protein (hs-CRP) or homeostasis model assessment of insulin resistance (HOMA-IR). TP53 was identified as the core target in Cr-induced AOB by network toxicology analysis. Further studies with larger samples are needed to confirm these findings.
24 September 2025 in The Journal of Nutritional Biochemistry
Metals disequilibrium is crucial in the progress of metabolic syndrome (MetS), whereas the underlying mechanism remains largely unclear. Aging is closely related with the major diseases, and recent studies show environmental exposure also accelerate aging. Therefore, we aimed at investigating the mediation impact of biological age (BA) on relationships of metals exposure with MetS risk. A cross-sectional study with 1,504 participants was conducted. BA predictors were established by Klemera and Doubal method (KDM) and Mahalanobis distance, based on clinical measures. KDM-accel [the residual difference of regressing KDM-BA to chronological age] and physiological dysregulation (PD) were further calculated and recorded as biological aging indexes (BAIs). Seven plasma metals (calcium, cobalt, copper, magnesium, molybdenum, selenium, and zinc), reported to be linked with MetS in our preceding study, were involved. Multivariate linear and logistic regression models were performed to evaluate the relationships of BAIs with metals exposure or MetS risk, respectively. The mediation effect of BA linking metals to MetS was also explored. Quantiles of magnesium, molybdenum, and cobalt showed significant negative relationships with MetS risk and two BAIs (all p-trend<0.05). Significant positive associations were observed for two BAIs and MetS risk (P<.001). Mediation analysis showed that BAIs mediated 19.15% and 13.23% of the negative associations between plasma molybdenum, magnesium and MetS risk, respectively. Our findings suggested that essential metals might reduce MetS risk via decelerating biological aging, emphasizing the significance of essential metals in prevention of aging and MetS.
Background: Hospital wastewater (HWW) is a critical reservoir for carbapenem-resistant Gram-negative bacteria. Methods: Between November 2024 and August 2025, sixty 24 h composite wastewater samples were collected from five tertiary hospitals. Of the 244 carbapenem-resistant isolates recovered, 34 blaNDM-1-positive Acinetobacter isolates were subjected to phenotypic, genotypic, and plasmid analyses. Results: Eleven species were identified among the 34 carbapenem-resistant Acinetobacter isolates, predominantly non-baumannii Acinetobacter (NBA). All isolates were carbapenem-resistant (34/34, 100%) with high-level MICs (meropenem MIC50/90, 32/64 mg/L; imipenem MIC50/90, >128/>128 mg/L); 21% (7/34) of isolates were resistant to colistin, and resistance to ceftazidime, cefepime, and trimethoprim-sulfamethoxazole was 100%, 94%, and 76%, respectively. Core-genome SNP analysis revealed highly similar isolates across hospitals within the same season (1-2 SNPs) or within the same hospital across seasons (19 SNPs). Genomic analysis showed that blaNDM-1 was present in all isolates (34/34, 100%), with plasmid carriage in 85.3% (29/34); blaOXA-58 co-occurred in 62.1% (18/29), mainly on Rep_3 plasmids (19/29), especially R3-T28 (15/29) that frequently carried blaOXA-58 (10/15). Two unclassified plasmids co-harboring blaNDM-1 and blaOXA-23 were detected in Acinetobacter tandoii isolates. The blaNDM-1 gene was embedded in a conserved Tn125-like structures with variable flanks. Conclusions: Overall, carbapenem-resistant Acinetobacter from hospital wastewater frequently carried Rep_3 plasmid-borne blaNDM-1, especially R3-T28 and often co-occurring with blaOXA-58, within a conserved Tn125-like core structures. These findings highlight HWW as a potential hotspot for dissemination of carbapenem resistance and support routine genomic surveillance under a One Health framework.
Fipronil (FPN), a widely used insecticide, poses health risks through environmental contamination. Although its toxicity is increasingly recognized, the impact of fipronil on glucose metabolism remains poorly understood. In this study, mice on a normal diet (ND) or high-fat diet (HFD) received a daily oral administration of fipronil (0, 0.25, 1, or 4 mg/kg) for 35 days. Blood glucose and insulin were measured, and glucose/insulin/pyruvate tolerance tests were performed. We found that fipronil compromised glucose tolerance in mice fed an ND. Gut microbiota composition was assessed by 16S rRNA sequencing and the expression of inflammatory factors was detected in the tissues. Serum fibroblast growth factor 15 (FGF15) and bile acid were determined. In HFD-fed mice, fipronil exacerbated glucose metabolic disorders and enhanced insulin resistance. These metabolic disturbances were associated with gut microbiota dysbiosis, particularly a marked reduction in Akkermansia muciniphila (A. muciniphila) abundance, and increased systemic inflammation. Fipronil exposure also decreased serum FGF15 and elevated serum bile acids. Our results suggest that fipronil disrupts glucose metabolism in association with gut microbiota alterations, impairment of the FGF15-bile acid axis, and induction of inflammation, highlighting its potential relevance to diabetes risk. Further studies are warranted to validate our findings.
18 August 2026 in Journal of Agricultural and Food Chemistry